QYUNS-B (02509) spent about HK$944,200 to buy back 57,200 shares on June 2nd.
Chun Shin Biotech-B (02509) announced the repurchase of approximately 57,200 shares at a cost of about HK$944,200 on June 2, 2026.
QYUNS-B (02509) announced that on June 2, 2026, it spent approximately HK$944,200 to repurchase 57,200 shares.
Related Articles
CONTIOCEAN (02613) has been granted approval for full circulation of H shares by the Hong Kong Stock Exchange.
Only a "cabbage price" underwriting fee for a fundraising of 75 billion? SpaceX is rumored to be seeking to reduce IPO underwriting fees, 23 securities firms still expected to receive 5 billion in commissions.
Sichuan Jiuzhou Electric (000801.SZ): Jiuzhou Investment and some directors and executives plan to collectively increase their holdings by 5.0875 million to 6.175 million shares.
CONTIOCEAN (02613) has been granted approval for full circulation of H shares by the Hong Kong Stock Exchange.
Only a "cabbage price" underwriting fee for a fundraising of 75 billion? SpaceX is rumored to be seeking to reduce IPO underwriting fees, 23 securities firms still expected to receive 5 billion in commissions.
Sichuan Jiuzhou Electric (000801.SZ): Jiuzhou Investment and some directors and executives plan to collectively increase their holdings by 5.0875 million to 6.175 million shares.
